¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Antigens, Tumor-Associated, Carbohydrate"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® carbohydrate ÇÑ±Û Åº¼öÈ­¹°
¼³¸í   
  Åº¼Ò¿Í ¹°ºÐÀڷΠÀÌ·ç¾îÁø À¯±âÈ­ÇÕ¹°. »ï´ë¿µ¾ç¼Ò °¡¿îµ¥ Çϳª·Î, ³ì»ö½Ä¹°ÀÇ ±¤ÇÕ¼ºÀ¸·Î »ý±ä´Ù. Æ÷µµ´ç, °ú´ç, ³ì¸» µûÀ§°¡ ÀÖ´Ù. ÀϹÝÀûÀ¸·Î Åº¼Ò-¼ö¼Ò-»ê¼ÒÀÇ ¼¼ ¿ø¼Ò·Î ÀÌ·ç¾îÁö´Â È­ÇÕ¹°·Î, ³ÐÀº ¶æÀ¸·Î´Â ´ç·ù-´çÁú°ú °°Àº ¶æÀ¸·Î ¾²ÀδÙ. ÀϹݽÄ(Cn(H2O)nÀÌ ¸¶Ä¡ Åº¼Ò¿Í ¹°ºÐÀÚ(H2O)·Î ÀÌ·ç¾îÁ® Àִ °Íó·³ º¸À̱⠶§¹®¿¡ ÀÌ·± À̸§ÀÌ ºÙ¾ú´Ù. ±×¸®°í »ê¼Ò ¿øÀÚ¼ö°¡ ÀϹݽĺ¸´Ù Çϳª ÀûÀº °Í, Áú¼Ò¿øÀÚ¸¦ ÇÔÀ¯Çϴ °Í, È²È­ÇÕ¹°À» ÇÔÀ¯Çϴ °Íµµ Åº¼öÈ­¹°¿¡ Æ÷ÇÔ½ÃŲ´Ù. È­ÇÐÀûÀ¸·Î´Â ´Ù°¡ ¾ËÄÚ¿ÃÀÇ ¾Ëµ¥È÷µå ¶Ç´Â ÄÉÅæ ¹× ±× À¯µµÃ¼ÀÇ ÃÑĪÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • T antigens
    TÇ׿ø
  • carbohydrate
    ź¼öÈ­¹°
  • carbohydrate broth
    ź¼öÈ­¹°Áó
  • carbohydrate intolerance
    ź¼öÈ­¹°¸ø°ßµõ(Áõ), ź¼öÈ­¹°ºÒ³»¼º
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • carbohydrate
    ź¼öÈ­¹°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • carbohydrate broth
    ź¼öÈ­¹°Áó
  • carbohydrate
    ź¼öÈ­¹°
  • carbohydrate disk
    ź¼öÈ­¹°¿ø¹Ý, ź¼öÈ­¹°µð½ºÅ©
  • carbohydrate intolerance
    ´çÁú¸ø°ßµõ(Áõ)
  • carbohydrate malabsorption syndrome
    ´çÁúÈí¼öºÒ·®ÁõÈıº
  • carbohydrate tolerance test
    ź¼öÈ­¹°³»¼º½ÃÇè
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • HLA= human leukocyte antigen ; hist ocompatibility antigens ; tran splan tation antigens
    HLA<Á¶Á÷ÀûÇÕÀ̽Ä>Ç׿ø, ÀιéÇ÷±¸Ç׿ø.
  • group specific C carbohydrate
    ±ºÆ¯ÀÌ C´Ù´çü.
  • group-specific C carbohydrate
    ±ºÆ¯ÀÌ C ź¼öÈ­¹°
  • HLA= human leukocyte antigen ; histocompatibility antigens ; transplantation anti
    HLA<Á¶Á÷ÀûÇÕÀ̽Ä>Ç׿ø, »ç¶÷¹éÇ÷±¸Ç׿ø.
  • Yka antigens
    YKa Ç׿ø
  • granulocyte-erythrocyte antigens
    °ú¸³±¸ÀûÇ÷±¸Ç׿ø
  • granulocyte-monocyte antigens
    °ú¸³±¸´Ü±¸Ç׿ø
  • granulocyte-monocyte-lymphocyte antigens
    °ú¸³±¸´Ü±¸¸²ÇÁ±¸Ç׿ø
  • granulocyte-platelet-lymphocyte antigens
    °ú¸³±¸Ç÷¼ÒÆÇ¸²ÇÁ±¸Ç׿ø
  • granulocyte-specific antigens
    °ú¸³±¸Æ¯ÀÌÇ׿ø
  • histocompatibility antigens
    Á¶Á÷ÀûÇÕ Ç׿ø
  • platelet-specific antigens
    Ç÷¼ÒÆÇƯÀÌÇ׿ø
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • granulocyte-erythrocyte antigens
    °ú¸³±¸ÀûÇ÷±¸Ç׿ø
  • granulocyte-monocyte antigens
    °ú¸³±¸´Ü±¸Ç׿ø
  • granulocyte-monocyte-lymphocyte antigens
    °ú¸³±¸´Ü±¸¸²ÇÁ±¸Ç׿ø
  • granulocyte-platelet-lymphocyte antigens
    °ú¸³±¸Ç÷¼ÒÆÇ¸²ÇÁ±¸Ç׿ø
  • granulocyte-specific antigens
    °ú¸³±¸Æ¯ÀÌÇ׿ø
  • histocompatibility antigens
    Á¶Á÷ÀûÇÕ Ç׿ø
  • human platelet antigens=HPA
    ÀÎÇ÷¼ÒÆÇÇ׿ø
  • platelet-specific antigens
    Ç÷¼ÒÆÇƯÀÌÇ׿ø
  • carbohydrate
    ´çÁú.
  • carbohydrate
    ź¼öÈ­¹°.
  • carbohydrate
    ź¼öÈ­¹°
  • carbohydrate
    ´çÁú(ÓØòõ)
  • carbohydrate
    ź¼öÈ­¹°(÷©â©ûùÚª)
  • carbohydrate broth
    ´çÁúºÎ¿ë.
  • carbohydrate disk
    ź¼öÈ­¹°ÆÇ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Metabolic defect of carbohydrate (Galactosemia)
    ź¼öÈ­¹°´ë»ç°áÇÔ(°¥¶ôÅä¿À½ºÇ÷Áõ)
    [¿¾ ¿ë¾î] ź¼öÈ­¹°´ë»ç°áÇÔ(°¥¶ôÅä¿À½ºÇ÷Áõ)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • active carbohydrate
    Ȱ¼º´çÁú (üÀàõÓØòõ)
  • carbohydrate
    ´çÁú(ÓØòõ)
  • carbohydrate tolerance test
    ´çÁú ºÎÇϽÃÇè(ÓØòõݶùÃãËúÐ)
  • derived carbohydrate
    À¯µµ´çÁú(ë¯ÓôÓØòõ)
  • carcinoembryonic antigens
    ¾Ï¹è¾ÆÇ׿ø(äßÛÏä´ù÷ê«)
  • class II MHC antigens
    "Á¦ 11 ·ù(×¾) MHC Ç׿ø(ù÷ê«), (ÔÒ) 1-region-associated antigens"
  • Epa antigens
    EPa Ç׿ø(ù÷ê«)
  • H-2 antigens
    H-2 Ç׿ø(ù÷ê«)
  • HLA antigens
    HLA Ç׿ø (ù÷ê«)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • carbohydrate
    ´çÁú, ź¼öÈ­¹°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CD cadaver donor; canine distemper; canine dose; carbohydrate dehydratase; carbon dioxide; cardiac dise...
AFP Alpha(¥á) Feto-Protein [HP 1826, 1858, 1859, 2265]
  ; Oncofetal Antigens
 &nbs...
Anti-ENA Anti-Extractable Nuclear Antigens
CEA Carcino-Embryonic Antigen [HP 1825-6]
  ; Oncofetal Antigens
  ; Glycopro...
CREG Cross REactive Group (of HLA Antigens)
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HLA Histocompatibility Antigens
Ipa Invasion plasmid antigens
MHC Major histocompatibility antigens
MAA Melanoma-associated antigens
MiHA Minor histocompatibility antigens
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • carbohydrate
    ´çÁú, ź¼öÈ­¹°
    ´Ù°¡ ¾ËÄÝ, ƯÈ÷ 5°¡ ¹× 6°¡ ¾ËÄÝÀÇ ¾Ëµ¥ÇÏÀ̵å ȤÀº Űſ À¯µµÃ¼ ¼ö¼Ò¿Í »ê¼Ò°¡ º¸Åë ¹°°ú °°Àº ºñÀ²·Î ÇÔÀ¯µÇ¹Ç·Î
  • carbohydrate fermentation test
    ź¼öÈ­¹° ¹ßÈ¿ ½ÃÇè
  • carbohydrate intolerance
    ´çÁú ºÒ³»¼º
  • carbohydrate metabolism disorder
    ź¼öÈ­¹° ´ë»ç Àå¾Ö
  • carbohydrate tolerance
    ź¼öÈ­¹° ºÎÇÏ, ź¼öÈ­¹° ³»Àμº
  • carbohydrate utilization test
    ź¼öÈ­¹° ÀÌ¿ë ½ÃÇè
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
antigens, tumour-associated, carbohydrate Carbohydrate antigens expressed by malignant tissue. They are useful as tumour markers and are measured in the serum by means of a radioimmunoassay employing monoclonal antibodies.
(12 Dec 1998)
carbohydrate <biochemistry> Very abundant compounds, usually an aldehyde or ketone derivative of a polyhydric alcohol, particularly of the pentahydric and hexahydric alcohols. They are so named because the hydrogen and oxygen are usually in the proportion to form water with the general formula Cn(H2O)n. The most important carbohydrates are the starches, sugars, celluloses and gums.
They are classified into mono, di, tri, poly and heterosaccharides. The smallest are monosaccharides like glucose whereas polysaccharides such as starch, cellulose or glycogen can be large and indeterminate in length.
(08 Oct 1997)
carbohydrate conformation The characteristic 3-dimensional shape of a carbohydrate.
(12 Dec 1998)
carbohydrate-deficient glycoprotein syndrome <syndrome> An inborn error of carbohydrate metabolism manifesting as a genetic multisystem disorder of autosomal recessive inheritance. A predominant feature is severe central and peripheral nervous system involvement resulting in psychomotor retardation, seizures, cerebellar ataxia, and other symptoms which include growth retardation, retinitis pigmentosa, hypothyroidism, and fatty liver. The notable biochemical feature is the deficiency of a large number of blood glycoproteins and decreased activities of various blood coagulation factors.
(12 Dec 1998)
carbohydrate dehydrogenases <enzyme> Reversibly catalyze the oxidation of a hydroxyl group of carbohydrates to form a keto sugar, aldehyde or lactone. Any acceptor except molecular oxygen is permitted.
Registry number: EC 1.1.
(12 Dec 1998)
carbohydrate epimerases <enzyme> Enzymes that catalyze the epimerization of chiral centres within carbohydrates or their derivatives.
Registry number: EC 5.1.3
(12 Dec 1998)
carbohydrate-induced hyperlipaemia type III familial hyperlipoproteinaemia, type IV familial hyperlipoproteinaemia
carbohydrate loading A procedure popular with long-distance runners and other athletes of filling muscles with a large glycogen pool prior to an athletic event; often, the athlete consumes very few carbohydrates for three days followed by a largely carbohydrate diet for the last three days before the event.
(05 Mar 2000)
carbohydrate metabolism <biochemistry> The breakdown of starches and sugars into smaller units that can be used by the body for energy.
(27 Sep 1997)
carbohydrate sequence The sequence of carbohydrates within polysaccharides, glycoproteins, and glycolipids.
(12 Dec 1998)
carbohydrate utilization test A test for the definitive identification of clinically important yeasts and yeastlike organisms.
(05 Mar 2000)
C carbohydrate antigen An antigen found in the cell wall of Streptococcus pneumoniae.
See: beta-haemolytic streptococci.
(05 Mar 2000)
combined fat-and carbohydrate-induced hyperlipaemia Hyperlipoproteinaemia characterised by increased plasma levels of chylomicrons, VLDL, pre-beta-lipoproteins, and triglycerides, and slight rise of cholesterol on a normal diet, with beta-lipoproteins normal; may be accompanied by bouts of abdominal pain, hepatosplenomegaly, susceptibility to atherosclerosis, and abnormal glucose tolerance; probably autosomal recessive inheritance.
Synonym: combined fat-and carbohydrate-induced hyperlipaemia, familial hyperchylomicronaemia with hyperprebetalipoproteinaemia, mixed hyperlipaemia.
(05 Mar 2000)
complex carbohydrate <biochemistry> The combination of carbohydrates and fibre.
(05 Jan 1998)
dietary carbohydrate <nutrition> Carbohydrates present in food comprising digestible sugars and starches and indigestible cellulose and other dietary fibres.
The former are the major source of energy. The sugars are in beet and cane sugar, fruits, honey, sweet corn, corn syrup, milk and milk products, etc.; the starches are in cereal grains, legumes, tubers, etc.
(21 Jun 2000)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Antigens, Tumor-Associated, Carbohydrate - »õâ Carbohydrate antigens expressed by malignant tissue. They are useful as tumor markers and are measured in the serum by means of a radioimmunoassay employing monoclonal antibodies.
    Synonyms : Antigen, Carcinoma-Associated, CA Antigen, CA(Oxford) Antigen, Carcinoma-Associated Antigen, Epitectin, Antigen, CA, Antigen, Carcinoma Associated, Antigens, CA, Antigens, Cancer-Associated Carbohydrate, Antigens, Tumor-Associated Carbohydrate
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • carbohydrate
    ź¼öÈ­¹°
  • carbohydrate
    ź¼öÈ­¹°;ÇÔ¼öź¼Ò;ź¼öÈ­¹°ÀÌ ¸¹Àº ½Äǰ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á